Cargando…

Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia

Histone lysine specific demethylase 1 (LSD1) has emerged as an attractive molecule target for the discovery of potently anticancer drugs to treat leukaemia. In this study, a series of novel chalcone derivatives were designed, synthesised and evaluated for their inhibitory activities against LSD1 in ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yang, Sun, Ying, Zhou, Yang, Li, Xinyang, Zhang, Huan, Zhang, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738283/ https://www.ncbi.nlm.nih.gov/pubmed/33307878 http://dx.doi.org/10.1080/14756366.2020.1852556

Ejemplares similares

Novel lysine‐specific histone demethylase 1 inhibitor in acute myeloid leukaemia transformed from essential thrombocythaemia
por: Hodges, Samantha, et al.
Publicado: (2021)

Chemical Inhibitors Targeting the Histone Lysine Demethylase Families with Potential for Drug Discovery
por: Das, Nando Dulal, et al.
Publicado: (2023)

Modulation of the activity of histone lysine methyltransferases and demethylases by curcumin analog in leukaemia cells
por: Sawesi, Suhila, et al.
Publicado: (2022)

Functional Characterization of the Lysine-Specific Histone Demethylases Family in Soybean
por: Liu, Mengshi, et al.
Publicado: (2022)

Histone lysine demethylases in Drosophila melanogaster
por: Holowatyj, Andreana, et al.
Publicado: (2015)

Discovery of a Highly Selective Cell‐Active Inhibitor of the Histone Lysine Demethylases KDM2/7
por: Gerken, Philip A., et al.
Publicado: (2017)

Histone demethylase lysine demethylase 5B in development and cancer
por: Han, Mengjiao, et al.
Publicado: (2016)

Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1
por: Zhou, Jiajun, et al.
Publicado: (2021)

Histone lysine demethylases in mammalian embryonic development
por: Shen, Hongjie, et al.
Publicado: (2017)

Expression pattern of histone lysine-specific demethylase 6B in gastric cancer
por: Wang, Shujun, et al.
Publicado: (2021)

Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
por: Majello, Barbara, et al.
Publicado: (2019)

The role of histone lysine demethylases in cancer cells’ resistance to tyrosine kinase inhibitors
por: White, Jasmine Cassar, et al.
Publicado: (2019)

Prominent role of histone lysine demethylases in cancer epigenetics and therapy
por: Janardhan, Avilala, et al.
Publicado: (2018)

The emerging role of histone lysine demethylases in prostate cancer
por: Crea, Francesco, et al.
Publicado: (2012)

Androgen Receptor and Histone Lysine Demethylases in Ovine Placenta
por: Cleys, Ellane R., et al.
Publicado: (2015)

Targeting histone lysine demethylases — Progress, challenges, and the future()
por: Thinnes, Cyrille C., et al.
Publicado: (2014)

Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2020)

Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma
por: Kim, Sangchul, et al.
Publicado: (2019)

Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
por: Shi, Ying, et al.
Publicado: (2018)

G-quadruplex RNA binding and recognition by the lysine-specific histone demethylase-1 enzyme
por: Hirschi, Alexander, et al.
Publicado: (2016)

Histone lysine-specific demethylase 1 regulates the proliferation of hemocytes in the oyster Crassostrea gigas
por: Gu, Xiaoyu, et al.
Publicado: (2022)

Crucial Role of Lysine-Specific Histone Demethylase 1 in RANKL-Mediated Osteoclast Differentiation
por: Ding, Mina, et al.
Publicado: (2023)

A protocol for high-throughput screening of histone lysine demethylase 4 inhibitors using TR-FRET assay
por: Wu, Qiong, et al.
Publicado: (2021)

The transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2
por: Lu, Shaoli, et al.
Publicado: (2015)

Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma
por: Zheng, Yang, et al.
Publicado: (2020)

Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells
por: Herrlinger, Eva‐Maria, et al.
Publicado: (2020)

Identification of the KDM2/7 Histone Lysine Demethylase Subfamily Inhibitor and its Antiproliferative Activity
por: Suzuki, Takayoshi, et al.
Publicado: (2013)

Synthetic Studies toward the Natural Product Tripartin, the First Natural Histone Lysine Demethylase Inhibitor
por: Dethe, Dattatraya H., et al.
Publicado: (2018)

Oocyte-Specific Knockout of Histone Lysine Demethylase KDM2a Compromises Fertility by Blocking the Development of Follicles and Oocytes
por: Xiong, Xianrong, et al.
Publicado: (2022)

Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A
por: Yang, Chao, et al.
Publicado: (2022)

Posttranslational Modifications of the Histone 3 Tail and Their Impact on the Activity of Histone Lysine Demethylases In Vitro
por: Lohse, Brian, et al.
Publicado: (2013)

The Histone H3 Lysine 27-Specific Demethylase Jmjd3 Is Required for Neural Commitment
por: Burgold, Thomas, et al.
Publicado: (2008)

Placenta specific gene targeting to study histone lysine demethylase and androgen signaling in ruminant placenta
por: Hord, Taylor Kimberly, et al.
Publicado: (2020)

Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
por: Chianese, Ugo, et al.
Publicado: (2022)

Epigenetic Control of Muscle Stem Cells: Focus on Histone Lysine Demethylases
por: Cicciarello, Delia, et al.
Publicado: (2022)

Distinct Roles of Histone Lysine Demethylases and Methyltransferases in Developmental Eye Disease
por: Reis, Linda M., et al.
Publicado: (2023)

The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer
por: Li, Jiaping, et al.
Publicado: (2019)

Lysine-specific histone demethylase 1 inhibition promotes reprogramming by facilitating the expression of exogenous transcriptional factors and metabolic switch
por: Sun, Hao, et al.
Publicado: (2016)

VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases
por: Ekstrom, Thomas L., et al.
Publicado: (2021)

Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)
por: Li, Zhonghua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t09f3s0v3eqi7i8h320rknt24r